Mesoblast

Mesoblast

Broadcast on: January 25, 2022
Duration: 10:28

Mesoblast is developing adult stem-cell therapies based on its proprietary MPC and MSC platforms. Its lead programmes are in pediatric aGvHD, heart failure, ARDS and lower back pain, all of which are in Phase III or later.

  • Chief Executive Officer & Managing Director

    Silviu Itescu, Chief Executive Officer & Managing Director, Mesoblast

    Dr. Itescu has served on Mesoblast's Board of Directors since the Company's founding in 2004, was Executive Director from 2007, and became Chief Executive Officer and Managing Director in 2011. Prior to founding Mesoblast, he established an international reputation as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation, and heart failure. Dr Itescu has been a faculty member of Columbia University in New York, and the University of Melbourne and Monash University in Australia. He has consulted for various international pharmaceutical companies, has been an adviser to biotechnology and health care investor groups, and has served on the Board of Directors of several publicly listed life sciences companies.

More from OETV

What's happening on OETV

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

X

We value your privacy

This website or its third party tools uses cookies, which are necessary for its functioning and required to achieve the purpose illustrated in our Privacy Policy. By clicking "Accept" or dismissing this notice, you agree to our website's use of cookies.